Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.120
+0.020 (0.95%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Grace Therapeutics Employees
Grace Therapeutics had 5 employees as of March 31, 2026. The number of employees decreased by 1 or -16.67% compared to the previous year.
Employees
5
Change (1Y)
-1
Growth (1Y)
-16.67%
Revenue / Employee
n/a
Profits / Employee
-$4,044,200
Market Cap
44.60M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 5 | -1 | -16.67% |
| Mar 31, 2025 | 6 | 2 | 50.00% |
| Mar 31, 2024 | 4 | -28 | -87.50% |
| Mar 31, 2020 | 32 | 4 | 14.29% |
| Mar 31, 2019 | 28 | 17 | 154.55% |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Celularity | 115 |
| Metagenomi Therapeutics | 113 |
| aTyr Pharma | 60 |
| NextCure | 40 |
| Mereo BioPharma Group | 39 |
| Actinium Pharmaceuticals | 27 |
| Veru Inc. | 20 |
GRCE News
- 5 days ago - Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference - GlobeNewsWire
- 15 days ago - Grace Therapeutics files to sell 4.76M shares of common stock for holders - TheFly
- 15 days ago - Grace Therapeutics Registration statement: Registration filing - Filings
- 26 days ago - Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update - GlobeNewsWire
- 26 days ago - Grace Therapeutics Quarterly report: Q1 2027 - Filings
- 26 days ago - Grace Therapeutics Earnings release: Q1 2027 - Filings
- 5 weeks ago - Grace Therapeutics to issue 4.762M shares at $2.10 in private placement - TheFly
- 5 weeks ago - Grace Therapeutics initiates dual-source manufacturing strategy for GTx-104 - TheFly